Tier 3 — preclinical
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity
Cell metabolism
2012
15; 6; 838-847
Bibliography
- PubMed
- PMID 22682224
- PubMed Central
- PMC3616313
- Funding
- Indexed grant support includes European Research Council. The complete funding declaration is not specified in the accessible abstract.
- Competing interests
- A complete competing-interest declaration is not specified in the accessible publication information.
Study snapshot
| Design | Preclinical animal study with supporting assays as applicable |
|---|---|
| Model | Mice and mammalian cells |
| Sample | Mouse and mammalian-cell experiments; group sizes vary |
| Intervention | NR supplementation in cells and high-fat-diet mouse models |
| Duration | Experimental feeding and laboratory protocols |
| Endpoints | Model-specific physiological outcomes; Biochemical or functional measures reported in the study |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
